Criteria for Advanced Prosthetic Foot Prescription

NCT ID: NCT03505983

Last Updated: 2025-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

91 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop criteria for prosthetic foot prescription for Veterans and Service Members with transtibial limb loss. The objectives are to: 1) Determine the appropriate functional outcome tests and measures to support the prescription of a type of Energy Storing and Returning (ESR) non-articulating, articulating or active plantarflexion prosthetic ankle-foot for a Veteran or Service Member with transtibial limb loss. 2) Correlate patient goals and subjective measures with objective data to determine the appropriate prosthetic ankle-foot category that will facilitate the greatest overall function to the user. 3) Develop criteria for the appropriate prescription of non-articulating ESR, articulating ESR, and active plantar flexion ESR ankle-foot units.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prosthesis User Amputation; Traumatic, Limb, Lower

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors
Outcomes assessor and statistician will be blinded to foot type during data processing and analysis

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Articulating ESR Prosthetic Foot First

Subjects will start with an Articulating ESR prosthetic foot first for 1 week, then will complete an additional week with the ESR prosthetic foot, and a powered prosthetic foot for 1 week.The final 4 weeks, all prosthetic feet will be available for use and subjects will self-select which foot to use for daily activities.

Group Type ACTIVE_COMPARATOR

Articulating ESR Prosthetic Foot First

Intervention Type DEVICE

Subjects will start with an articulating ESR foot first for 1 week, then will complete an additional week with an articulating ESR foot and a powered foot for 1 week. The final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

Powered Prosthetic Foot First

Subjects will start with a powered prosthetic foot first for 1 week, then will complete an additional week with an articulating ESR prosthetic foot and an ESR prosthetic foot for 1 week. The final 4 weeks, all prosthetic feet will be available for use and subjects will self-select which foot to use for daily activities.

Group Type ACTIVE_COMPARATOR

Powered Prosthetic Foot First

Intervention Type DEVICE

Subjects will start with a powered prosthetic foot first for 1 week, then will complete an additional week with an articulating ESR foot and an ESR foot for 1 week. The final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

ESR Prosthetic Foot First

Subject will start with an energy storing and returning (ESR) prosthetic foot first for 1 week, then will complete an additional week with an articulating ESR prosthetic foot, and a powered prosthetic foot for 1 week. During the final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

Group Type ACTIVE_COMPARATOR

ESR Prosthetic Foot First

Intervention Type DEVICE

Subjects will start with an ESR foot first for 1 week, then will complete an additional week with an articulating ESR foot and a powered foot for 1 week. The final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESR Prosthetic Foot First

Subjects will start with an ESR foot first for 1 week, then will complete an additional week with an articulating ESR foot and a powered foot for 1 week. The final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

Intervention Type DEVICE

Articulating ESR Prosthetic Foot First

Subjects will start with an articulating ESR foot first for 1 week, then will complete an additional week with an articulating ESR foot and a powered foot for 1 week. The final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

Intervention Type DEVICE

Powered Prosthetic Foot First

Subjects will start with a powered prosthetic foot first for 1 week, then will complete an additional week with an articulating ESR foot and an ESR foot for 1 week. The final 4 weeks of the study, all prosthetic feet will be available and subjects can self-select which foot to use.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Odyssey (College Park) Elan (Endolite) MotionFoot (Fillauer) Proflex (Ossur) Echelon (Endolite) Tribute (College Park) Proprio (Ossur) TruStep (College Park) Kinterra (Freedom Innovations) Flex Foot Balance with DP Flexion (Ossur) Raize (Fillauer) Echelon VT (Endolite) Triton Smart Ankle (Otto Bock) Venture (College Park) Kinnex (Freedom Innovations) emPOWER (Otto Bock)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DEERS eligible Veteran or Service Member, or civilian with unilateral transtibial amputation
* Currently using an Energy Storing and Returning prosthetic foot with a well-fitting socket as a primary or back-up prosthesis
* Achieved a "Modified Independence" score on the Functional Independence Measure (FIM) for the locomotion mobility items
* Has a minimum clearance of 8 ¾ inches to accommodate all feet

Exclusion Criteria

* Has active wounds/ulcers or significant musculoskeletal comorbidities on their intact limb that would impair their ability to participate in all functional outcome measures
* Has any comorbidity that results in rapid limb volume changes (i.e. end stage renal disease with dialysis),
* Weighs more than 275 pounds, the maximum product weight load
* Is unable or unwilling to comply with all research visits
* Has cognitive deficit(s) or mental health pathology limiting a subject's ability to participate fully in the study
* Women who are pregnant or plan to become pregnant during study activities. This will be determined by asking the participant if they are pregnant or if they believe that they may be pregnant. This question will only be asked at inclusion, as biomechanical changes will only be impacted if the woman is in the 2nd or 3rd trimester, and will not be impacted if the participant becomes pregnant while in the study.
* Poorly fitting socket
* Vision loss that requires use of an assistive device for gait
* Upper Limb Amputation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Walter Reed National Military Medical Center

FED

Sponsor Role collaborator

James A. Haley Veterans Administration Hospital

FED

Sponsor Role collaborator

VA Puget Sound Health Care System

FED

Sponsor Role collaborator

VA New York Harbor Healthcare System

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jason Maikos

Director, VISN 2 Gait and Motion Analysis Laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jason Maikos, PhD

Role: PRINCIPAL_INVESTIGATOR

Director, VISN 2 Gait and Motion Analysis Laboratory

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA New York Harbor Healthcare System

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Maikos JT, Hendershot BD, Pruziner AL, Hyre MJ, Chomack JM, Phillips SL, Heckman JT, Sidiropoulos AN, Dearth CL, Nelson LM. Criteria for Advanced Prosthetic Foot Prescription: Rationale, Design, and Protocol for a Multisite, Randomized Controlled Trial. JMIR Res Protoc. 2023 Apr 4;12:e45612. doi: 10.2196/45612.

Reference Type DERIVED
PMID: 37014672 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDMRP-OP150095

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

IRB #01603

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessing the DSR Ankle
NCT05955378 COMPLETED NA